Author

Roger Day

Observed names: Day, Roger, R Day, R S Day, R. Day, R.S. DAY, ROGER S. DAY, Roger S Day, Roger S. Day

Observed institutions: University of Maryland, Baltimore, Roswell Park Comprehensive Cancer Center, Harvard University, University of Pittsburgh, Magee-Womens Hospital, UPMC Hillman Cancer Center, University of Pittsburgh Medical Center, Ri.MED, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Cincinnati Medical Center

OpenAlex ID: A5109883106

Levels of TGF-α and EGFR Protein in Head and Neck Squamous Cell Carcinoma and Patient Survival

1998 · Jennifer Rubin Grandis, Mona F. Melhem, et al. · JNCI Journal of the National Cancer Institute · 1,123

Sharing Detailed Research Data Is Associated with Increased Citation Rate

2007 · Heather A. Piwowar, Roger S. Day, et al. · PLoS ONE · 973

Incorporating Toxicity Considerations Into the Design of Two-Stage Phase II Clinical Trials

1995 · John Bryant, Roger Day · Biometrics · 267

Reduced levels of XPA, ERCC1 and XPF DNA repair proteins in testis tumor cell lines

2004 · Carey Welsh, Roger Day, et al. · International Journal of Cancer · 222

PDF

Vitamin d inhibition of prostate adenocarcinoma growth and metastasis in the dunning rat prostate model system

1997 · Robert H. Getzenberg, Benjamin W. Light, et al. · Urology · 221

Calculation of lytic units for the expression of cell-mediated cytotoxicity

1992 · John Bryant, Roger Day, et al. · Journal of Immunological Methods · 219

Phase I study of a MUC1 vaccine composed of different doses of MUC1 peptide with SB-AS2 adjuvant in resected and locally advanced pancreatic cancer

2004 · Ramesh K. Ramanathan, Kenneth M. Lee, et al. · Cancer Immunology Immunotherapy · 218

PDF

MDR1 transcript levels as an indication of resistant disease in acute myelogenous leukaemia

1990 · H. Sato, H. Preisler, et al. · British Journal of Haematology · 182

Phase II trial of oral 1,25-dihydroxyvitamin D (calcitriol) in hormone refractory prostate cancer

1995 · Jennifer L. Osborn, Gary G. Schwartz, et al. · Urologic Oncology Seminars and Original Investigations · 167

PDF

The number of intratumoral dendritic cells and ?-chain expression in T cells as prognostic and survival biomarkers in patients with oral carcinoma

2001 · Torsten E. Reichert, Claudia Scheuer, et al. · Cancer · 166

PDF

Identifier mapping performance for integrating transcriptomics and proteomics experimental results

2011 · Roger S Day, Kevin K McDade, et al. · BMC Bioinformatics · 157

PDF

Absent or low expression of the zeta chain in T cells at the tumor site correlates with poor survival in patients with oral carcinoma.

1998 · T E Reichert, R Day, et al. · PubMed · 147

Predicting response to checkpoint inhibitors in melanoma beyond PD-L1 and mutational burden

2018 · Carl Morrison, Sarabjot Pabla, et al. · Journal for ImmunoTherapy of Cancer · 145

Low Overexpression of HER-2/Neu in Advanced Colorectal Cancer Limits the Usefulness of Trastuzumab (Herceptin®) and Irinotecan as Therapy. A Phase II Trial

2004 · Ramesh K. Ramanathan, Jimmy J. Hwang, et al. · Cancer Investigation · 140

Treatment sequencing, asymmetry, and uncertainty: protocol strategies for combination chemotherapy.

1986 · R S Day · PubMed · 132

Adjuvant radiation for vulvar carcinoma: Improved local control

1997 · Clare M. Faul, Dwight Mirmow, et al. · International Journal of Radiation Oncology*Biology*Physics · 127

Detection of bladder cancer using a novel nuclear matrix protein, BLCA-4.

2000 · B R Konety, T S Nguyen, et al. · PubMed · 123

Brain Tumor Volume Measurement: Comparison of Manual and Semiautomated Methods

1999 · Bonnie N. Joe, Melanie B. Fukui, et al. · Radiology · 111

Lymphatic Mapping With Isosulfan Blue Dye in Squamous Cell Carcinoma of the Head and Neck

1998 · Karen T. Pitman, Jonas T. Johnson, et al. · Archives of Otolaryngology - Head and Neck Surgery · 110

Direct relationship between remission duration in acute myeloid leukemia and cell cycle kinetics: a leukemia intergroup study

1990 · A Raza, HD Preisler, et al. · Blood · 98

PDF

Lung Cancer Serum Biomarker Discovery Using Glycoprotein Capture and Liquid Chromatography Mass Spectrometry

2010 · Xuemei Zeng, Brian L. Hood, et al. · Journal of Proteome Research · 94

Next generation sequencing of PD-L1 for predicting response to immune checkpoint inhibitors

2019 · Jeffrey M. Conroy, Sarabjot Pabla, et al. · Journal for ImmunoTherapy of Cancer · 91

Contextualized questioning to scaffold learning from simulations

1999 · Cindy Hmelo, Roger Day · Computers & Education · 75

A phase II trial of all- trans -retinoic acid in hormone-refractory prostate cancer: a clinical trial with detailed pharmacokinetic analysis

1997 · D. L. Trump, David C. Smith, et al. · Cancer Chemotherapy and Pharmacology · 63

Adaption of bivariate frailty models for prediction, with application to biological markers as prognostic indicators

1997 · R Day · Biometrika · 57

Works count: 99

Citation count: 6,331

H-index: 36

I10-index: 56